The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of the combination of subcutaneous bortezomib (Bortez) and pegylated liposomal doxorubicin (PLD) for the treatment of patients with acute myelogenous leukemia (AML).
 
Ben Kent Tomlinson
No Relationships to Disclose
 
Joseph M. Tuscano
Honoraria - Celgene; Onyx
Research Funding - Celgene; GlaxoSmithKline; Millennium
 
Mehrdad Abedi
Honoraria - Millennium
Speakers' Bureau - Millennium
Research Funding - Millennium
Travel, Accommodations, Expenses - Millennium
 
Jeanna Welborn
No Relationships to Disclose
 
Robert O'Donnell
Research Funding - Genentech; Novocure
 
Mili Arora
No Relationships to Disclose
 
Radha Verman
No Relationships to Disclose
 
Kelly Jones
No Relationships to Disclose
 
Brian Andrew Jonas
Consulting or Advisory Role - GlycoMimetics
Speakers' Bureau - Celgene
Research Funding - Abbvie; Ambit BioSciences; KaloBios
Travel, Accommodations, Expenses - GlycoMimetics